Last reviewed · How we verify
biological monitoring
biological monitoring is a Biologic drug developed by University of Roma La Sapienza. It is currently FDA-approved.
Biological monitoring, developed by the University of Roma La Sapienza, is a marketed product with a key composition patent expiring in 2028. The primary strength of this drug lies in its established market presence, leveraging the university's research expertise. The primary risk is the patent expiry in 2028, which could lead to increased competition from generics.
At a glance
| Generic name | biological monitoring |
|---|---|
| Sponsor | University of Roma La Sapienza |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Using Smartwatches to Monitor Smoking in Real-life Situations
- Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer (PHASE3)
- Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial (PHASE2)
- Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma (PHASE2)
- Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy (PHASE2)
- Pro-inflammatory Cytokines in Facioscapulohumeral Muscular Dystrophy (CYTOKINE-FSH) (NA)
- Kaempferol Absorption and Pharmacokinetics Evaluation (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- biological monitoring CI brief — competitive landscape report
- biological monitoring updates RSS · CI watch RSS
- University of Roma La Sapienza portfolio CI
Frequently asked questions about biological monitoring
What is biological monitoring?
Who makes biological monitoring?
What development phase is biological monitoring in?
Related
- Manufacturer: University of Roma La Sapienza — full pipeline
- Compare: biological monitoring vs similar drugs
- Pricing: biological monitoring cost, discount & access